Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment.
نویسندگان
چکیده
The CD1 proteins are major histocompatibility complex class I-like molecules specialized in presenting lipid and glycolipid antigens to T cells. Group I CD1s include CD1a, CD1b, and CD1c and present bacterial antigens to a diverse repertoire of pathogen-specific T cells. In contrast, CD1d presents endogenous and exogenous ligands to invariant natural killer T cells. Different subsets of dendritic cells (DCs) express distinct CD1 profiles. Myeloid DCs (mDCs) in the blood express CD1d, whereas Langerhans cells in the skin express CD1a, suggesting that signals present in the microenvironment regulate these antigen presentation pathways. We have reported previously that IgG regulates the expression of CD1 molecules on human DCs in vitro, via an CD32a (FcgRIIa)–dependent mechanism. In the present study, we took advantage of the low IgG levels in treatment-naı̈ve patients with common variable immunodeficiency (CVID) to investigate if IgG might regulate the CD1 expression profile also in vivo. Peripheral blood mononuclear cells isolated from 13 patients newly diagnosed with CVID according to the criteria established by the Pan-American Group for Immunodeficiency before the onset of intravenous immunoglobulin (IVIg) replacement therapy were analyzed by flow cytometry. Approval was obtained from the University of Sao Paulo institutional review board for these studies, and informed consent was provided according to the Declaration of Helsinki. mDCs were defined as CD3-CD14-CD19-CD56-CD11c1 HLA-DR1 (Figure 1A). The proportion of mDCs expressing CD1c was elevated in treatment-naı̈ve patients with CVID compared with healthy control participants (Figure 1B). Interestingly, this subset bias was normalized after 12 months of IVIg treatment (Figure 1B). Next, we investigated the expression of CD1a, CD1b, and CD1d on the CD1c1 mDC subset. As expected, CD1a and CD1b were essentially undetectable on CD1c1 mDCs from healthy control participants (Figure 1C-D), whereas CD1d was ubiquitously
منابع مشابه
IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa.
Dendritic cells (DCs) process and present bacterial and endogenous lipid antigens in complex with CD1 molecules to T cells and invariant natural killer T (NKT) cells. However, different types of DCs, such as blood myeloid DCs and skin Langerhans cells, exhibit distinct patterns of CD1a, CD1b, CD1c, and CD1d expression. The regulation of such differences is incompletely understood. Here, we init...
متن کاملThe Significance of B-cell Subsets in Patients with Unclassified Hypogammaglobulinemia and Association with Intravenous Immunoglobulin Replacement Requirement
Background: Patients with unclassified hypogammaglobulinemia (UCH) constitute a diagnostic and therapeutic dilemma, because information concerning the clinical and immunological characteristics of these patients is insufficient. Objective: To evaluate B-cell subsets in cases with UCH and common variable immunodeficiency (CVID) and their association with treatment requirement in UCH patients. Me...
متن کاملIVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID
Common variable immunodeficiency (CVID) is characterized by defective B cell function, impaired antibody production, and increased susceptibility to bacterial infections. Here, we addressed the hypothesis that poor antibody-mediated immune control of infections may result in substantial perturbations in the T cell compartment. Newly diagnosed CVID patients were sampled before, and 6-12 months a...
متن کاملIn Vivo Effects of Calcitriol on Phenotypic and Functional Properties of Dendritic Cells
Background: Dendritic cells (DCs) play a central role in the initiation and expansion of T cell mediated immune responses with potential immunotherapy application. The compounds which have the ability to induce immunomodulatory effects on DCs may be employed for the treatment of immunopathologic conditions such as autoimmune diseases. Objective: The aim of this study was to investigate the in v...
متن کاملImmunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy
OBJECTIVE The objective of the study was to profile leukocyte markers modulated during intravenous immunoglobulin (IVIg) treatment, and to identify markers and immune pathways associated with clinical efficacy of IVIg for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with potential for monitoring treatment efficacy. METHODS Response to IVIg treatment in newly diagnosed IVIg...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Blood
دوره 121 24 شماره
صفحات -
تاریخ انتشار 2013